NewsRx

Search our medical news database

Pre-Eclampsia

Irregular Growth Factor Levels Mark Heightened Risk During Pregnancy

Published in Women's Health Weekly, August 23rd, 2001

by Sonia Nichols, senior medical writer - Monitoring plasma levels of an important human growth factor might clue doctors in to a pregnant patient's risk for developing pre-eclampsia.

Based on a study of 60 pregnant women with mild or severe pre-eclampsia, doctors say plasma levels of a growth factor responsible for new blood vessel growth and permeability called VEGF (vascular endothelial growth factor) tend to rise in pre-eclamptic women to such high levels that those values can discriminate mild disease from severe disease.

The rise in VEGF levels in women with pre-eclampsia appears to be caused by a complex cascade of biochemical events,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook